Arkolith/Insider Trading/CTIC/Form 4

Biotechnology Value Fund L P

Director, 10% OwnerCTI BIOPHARMA CORP (CTIC) · full profile →Form 4 · filed Jun 28, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
18
5 non-derivative · 13 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 26, 2023Tender(U)4.0M$9.10$36.3M0
Jun 26, 2023Tender(U)2.6M$9.10$23.6M0
Jun 26, 2023Tender(U)43K$9.10$393K0
Jun 26, 2023Tender(U)1.5M$9.10$13.9M0
Jun 26, 2023Tender(U)703K$9.10$6.4M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 26, 2023Tender(U)17——0
Jun 26, 2023Disposed to issuer(D)80K——0
Jun 26, 2023Disposed to issuer(D)80K——0
Jun 26, 2023Disposed to issuer(D)80K——0
Jun 26, 2023Disposed to issuer(D)50K——0
Jun 26, 2023Tender(U)2K——0
Jun 26, 2023Tender(U)1K——0
Jun 26, 2023Tender(U)191——0
Jun 26, 2023Tender(U)12——0
Jun 26, 2023Tender(U)344——0
Jun 26, 2023Tender(U)239——0
Jun 26, 2023Disposed to issuer(D)120K——0
Jun 26, 2023Disposed to issuer(D)60K——0

Transaction Codes

U
See SEC Form 4 code table
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000921895-23-001602) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML